Reducing Cardiovascular Risk in Type 2 Diabetes
- 30 January 2003
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (5) , 457-459
- https://doi.org/10.1056/nejme020172
Abstract
Mortality from cardiovascular disease is increased by a factor of two to three in persons with diabetes as compared with the general population.1 Cardiovascular disease develops earlier in the presence of diabetes and occurs as often in diabetic women as in diabetic men. To reduce this increased risk, a multifactorial approach to the management of type 2 diabetes has been advocated. The American Diabetes Association, for example, recommends not only good glycemic control but also identification and aggressive treatment of associated cardiovascular risk factors, with more stringent target levels for lipids and blood pressure than those recommended for the general . . .Keywords
This publication has 15 references indexed in Scilit:
- Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 DiabetesNew England Journal of Medicine, 2003
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2003
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyPublished by Elsevier ,2002
- Age and the Burden of Death Attributable to Diabetes in the United StatesAmerican Journal of Epidemiology, 2002
- Physical Activity and Risk for Cardiovascular Events in Diabetic WomenAnnals of Internal Medicine, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996